AstraZeneca's diabetes drug curbs heart failure, kidney risks
(Reuters) – The biggest clinical trial so far to assess a new class of diabetes pills shows that AstraZeneca’s Farxiga can prevent heart failure and cut the risk of kidney problems in a broad range of patients. FILE PHOTO: A man walks past a sign at an AstraZeneca site in Macclesfield, central England May 19,… Read More »